Page last updated: 2024-08-16

triazolam and zaleplon

triazolam has been researched along with zaleplon in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (8.70)18.2507
2000's16 (69.57)29.6817
2010's5 (21.74)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Griebel, G; Perrault, G; Sanger, DJ1
Frey, JM; Griffiths, RR; Rush, CR1
Cevallos, WH; Furlan, PM; Leister, CA; Lucki, I; Mangano, R; Martin, PT; Troy, SM; Unruh, MA1
Lelas, S; Rowlett, JK; Spealman, RD1
Ator, NA1
Ator, NA; Griffiths, RR; Kaminski, BJ; Kautz, MA; Weerts, EM1
Kitazumi, K; Mori, M; Noguchi, H; Shiba, T2
Biggio, G; Busonero, F; Carta, M; Maciocco, E; Massa, F; Peis, M; Sanna, E; Talani, G1
Feck, AS; Goodchild, JH; Silverman, MD1
Kitazumi, K; Mori, M; Noguchi, H; Shiba, T; Shiobara, Y1
Foster, AC; Grigoriadis, DE; Gross, RS; Petroski, RE; Sullivan, SK; Verge, G1
Flanagan, D; Goodchild, JH1
Beck, FM; Dietrich, T; Ganzberg, SI; Valerin, M1
Merin, RL1
Greenblatt, DJ; Zammit, GK1
Cook, JM; Makaron, L; Moran, CA; Namjoshi, O; Rallapalli, S; Rowlett, JK1
Ator, NA; Biawat, P; Clayton, T; Cook, JM; Rallapalli, SK; Soto, PL; Weed, MR1

Reviews

2 review(s) available for triazolam and zaleplon

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Comparison of triazolam and zaleplon for sedation of dental patients.
    Dentistry today, 2005, Volume: 24, Issue:9

    Topics: Acetamides; Anti-Anxiety Agents; Conscious Sedation; Dental Anxiety; GABA Modulators; Humans; Hypnotics and Sedatives; Pyrimidines; Triazolam

2005

Trials

3 trial(s) available for triazolam and zaleplon

ArticleYear
Zaleplon and triazolam in humans: acute behavioral effects and abuse potential.
    Psychopharmacology, 1999, Volume: 145, Issue:1

    Topics: Acetamides; Adolescent; Adult; Behavior; Behavior, Addictive; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Illicit Drugs; Male; Observer Variation; Pyrimidines; Triazolam

1999
Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
    Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:3

    Topics: Acetamides; Adolescent; Adult; Affect; Association Learning; Attention; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Learning; Male; Memory; Mental Recall; Middle Aged; Psychomotor Performance; Pyridines; Pyrimidines; Sex Characteristics; Surveys and Questionnaires; Triazolam; Zolpidem

2000
Zaleplon (Sonata) oral sedation for outpatient third molar extraction surgery.
    Anesthesia progress, 2005,Winter, Volume: 52, Issue:4

    Topics: Acetamides; Adolescent; Adult; Ambulatory Surgical Procedures; Anesthesia Recovery Period; Anesthesia, Dental; Anti-Anxiety Agents; Anxiety; Conscious Sedation; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Memory; Molar, Third; Pyrimidines; Tooth Extraction; Triazolam

2005

Other Studies

18 other study(ies) available for triazolam and zaleplon

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.
    Journal of psychopharmacology (Oxford, England), 1998, Volume: 12, Issue:4

    Topics: Acetamides; Animals; Anti-Anxiety Agents; Avoidance Learning; Azabicyclo Compounds; Benzodiazepines; Escape Reaction; Hypnotics and Sedatives; Male; Maze Learning; Motor Activity; Piperazines; Punishment; Pyridines; Pyrimidines; Rats; Rats, Wistar; Triazolam; Zolpidem

1998
Transduction of the discriminative stimulus effects of zolpidem by GABA(A)/alpha1 receptors.
    European journal of pharmacology, 2000, Oct-06, Volume: 406, Issue:1

    Topics: Acetamides; Animals; Diazepam; Discrimination, Psychological; Dose-Response Relationship, Drug; GABA Agonists; GABA Modulators; GABA-A Receptor Agonists; Male; Protein Subunits; Pyridines; Pyrimidines; Reinforcement Schedule; Saimiri; Triazolam; Zolpidem

2000
Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons.
    Drug and alcohol dependence, 2000, Dec-22, Volume: 61, Issue:1

    Topics: Acetamides; Animals; Behavior, Animal; Discrimination Learning; Dose-Response Relationship, Drug; GABA Modulators; Hypnotics and Sedatives; Male; Papio; Pyrimidines; Self Administration; Triazolam

2000
Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.
    Drug and alcohol dependence, 2000, Dec-22, Volume: 61, Issue:1

    Topics: Acetamides; Animals; Dose-Response Relationship, Drug; GABA Modulators; Hypnotics and Sedatives; Male; Papio; Psychomotor Performance; Pyrimidines; Substance-Related Disorders; Time Factors; Triazolam

2000
Effect of zaleplon on learning and memory in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2002, Volume: 366, Issue:2

    Topics: Acetamides; Animals; Avoidance Learning; Binding Sites; Binding, Competitive; Dose-Response Relationship, Drug; Flunitrazepam; GABA Modulators; Hippocampus; Inhibitory Concentration 50; Male; Maze Learning; Memory; Nitrazepam; Pyrimidines; Rats; Rats, Inbred F344; Receptors, GABA-A; Triazolam

2002
Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes.
    European journal of pharmacology, 2002, Sep-13, Volume: 451, Issue:2

    Topics: Acetamides; Animals; Cerebral Cortex; Female; Humans; Male; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Triazolam; Xenopus laevis; Zolpidem

2002
Anxiolysis in general dental practice.
    Dentistry today, 2003, Volume: 22, Issue:3

    Topics: Acetamides; Adjuvants, Anesthesia; Anesthesia, Dental; Anesthetics, Inhalation; Anti-Anxiety Agents; Clinical Protocols; Conscious Sedation; Dental Anxiety; Diazepam; GABA Modulators; General Practice, Dental; Humans; Hydroxyzine; Hypnotics and Sedatives; Lorazepam; Midazolam; Nitrous Oxide; Pyrimidines; Triazolam

2003
Effect of zaleplon, a non-benzodiazepine hypnotic, on melatonin secretion in rabbits.
    Journal of pharmacological sciences, 2003, Volume: 93, Issue:2

    Topics: Acetamides; Animals; Azabicyclo Compounds; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Electroencephalography; Hypnotics and Sedatives; Male; Melatonin; Pineal Gland; Piperazines; Pyrimidines; Rabbits; Rats; Rats, Sprague-Dawley; Triazolam

2003
Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats.
    Journal of pharmacological sciences, 2004, Volume: 94, Issue:3

    Topics: Acetamides; Administration, Oral; Animals; Azabicyclo Compounds; Cerebral Cortex; Dose-Response Relationship, Drug; Electrodes, Implanted; Electroencephalography; Hypnotics and Sedatives; Male; Nitrazepam; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Sleep Initiation and Maintenance Disorders; Sleep Stages; Triazolam; Upper Extremity

2004
Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptor.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 311, Issue:2

    Topics: Acetamides; Animals; Azides; Benzodiazepines; Binding Sites; Brain; Cell Membrane; Cerebellum; Cerebral Cortex; Chloride Channels; Flumazenil; GABA Modulators; gamma-Aminobutyric Acid; Kinetics; Male; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Thiophenes; Triazolam; Tritium; Zolpidem

2004
Adult oral sedation in California: what can a dentist do without a special permit or certificate from the Dental Board of California?
    Journal of the California Dental Association, 2006, Volume: 34, Issue:12

    Topics: Acetamides; Administration, Oral; Adult; Anesthesia, Dental; Anesthesiology; Anti-Anxiety Agents; California; Conscious Sedation; Dental Anxiety; Drug Interactions; Humans; Hypnotics and Sedatives; Licensure; Lorazepam; Practice Guidelines as Topic; Pyrimidines; Specialty Boards; Triazolam

2006
Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications.
    Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:12

    Topics: Acetamides; Adult; Aged; Azabicyclo Compounds; Clinical Trials as Topic; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Eszopiclone; Half-Life; Hepatic Insufficiency; Humans; Hypnotics and Sedatives; Piperazines; Pyridines; Pyrimidines; Receptors, GABA-A; Sleep; Sleep Initiation and Maintenance Disorders; Triazolam; United States; Zolpidem

2012
Cognition-impairing effects of benzodiazepine-type drugs: role of GABAA receptor subtypes in an executive function task in rhesus monkeys.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 104

    Topics: Acetamides; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Carbolines; Cognition; Executive Function; Female; GABA-A Receptor Antagonists; Hypnotics and Sedatives; Imidazoles; Macaca mulatta; Pyridines; Pyrimidines; Receptors, GABA-A; Triazolam; Zolpidem

2013
Allosteric modulation of GABA(A) receptor subtypes:effects on visual recognition and visuospatial working memory in rhesus monkeys [corrected].
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2013, Volume: 38, Issue:11

    Topics: Acetamides; Allosteric Regulation; Animals; Benzodiazepines; Conditioning, Operant; Diazepam; Dose-Response Relationship, Drug; Imidazoles; Macaca mulatta; Male; Memory, Short-Term; Pyridazines; Pyridines; Pyrimidines; Receptors, GABA-A; Recognition, Psychology; Triazolam; Triazoles; Zolpidem

2013